| Literature DB >> 33623424 |
Philipp Baumbach1, Ruth Zaslansky1, Ana Lilia Garduño-López2, Victor Manuel Acosta Nava2, Lisette Castro Garcés2, Dulce María Rascón-Martínez3, Luis Felipe Cuellar-Guzmán4, Maria Esther Flores-Villanueva5, Elizabeth Villegas-Sotelo6, Orlando Carrillo-Torres7, Hugo Vilchis-Sámano8, Mariana Calderón-Vidal9, Gabriela Islas-Lagunas10, C Richard Chapman11, Marcus Komann1, Winfried Meissner1.
Abstract
OBJECTIVE: This was a pre-post study in a network of hospitals in Mexico-City, Mexico. Participants developed and implemented Quality Improvement (QI) interventions addressing perioperative pain management.Entities:
Keywords: acute pain; auditing; patient-reported outcomes; perioperative pain management; quality improvement; surgery
Year: 2021 PMID: 33623424 PMCID: PMC7894852 DOI: 10.2147/JPR.S282850
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Figure 1The flow chart depicts patient recruitment during the two project phases.
Patient Demographics. Findings are Shown Separately for the Two Study Phases
| Phase 1 | Phase 2 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | Sample | n | % | Sample | |||||||
| Sex: male | 568 | 41.7 | 1361 | 518 | 40.4 | 1282 | ||||||
| Comorbidity | 997 | 73 | 1367 | 981 | 76 | 1287 | ||||||
| Receipt of an opioid before admission to hospital | 69 | 5.2 | 1329 | 91 | 7.1 | 1280 | ||||||
| Persistent pain before surgery | 579 | 42.7 | 1357 | 491 | 38.3 | 1282 | ||||||
| Age (years) | 52.0 | 39.0 | 64.0 | 1355 | 54.0 | 41.0 | 66.0 | 1281 | ||||
| Duration of surgery (hours) | 2.1 | 1.5 | 3.3 | 1284 | 2.5 | 1.7 | 4.0 | 1265 | ||||
| Intensity of persistent pain (NRS 0–10) | 8.0 | 5.0 | 10.0 | 565 | 8.0 | 6.0 | 9.0 | 483 | ||||
Figure 2Distribution of the relative frequencies of the patient-reported outcomes are shown in (A) and for processes in (B). Each dot represents summarized data from one ward. Box plots filled in with gray, represent data for the first project phase and white plots represent data for the second phase.
Figure 3Changes due to the QI work at the network level. The marginal effects for project phase on the patient-reported outcomes are shown in the upper panel, shaded in light gray, and the process variables are portrayed in the lower panel, shaded in dark gray. Squares depict the relative risk regarding project phases obtained by regression modelling and the black horizontal lines indicate the corresponding 95 % confidence intervals. *p < 0.05, **p < 0.01, ***p < 0.001, p-values were not adjusted for multiple comparisons.
Figure 4Results of the single ward analysis and whether improvement took place and its effect size. Cells with a green background indicate improvement, whereas, red signifies worsening of the PRO or decreased implementation of the process in phase 2. The effect size for each item is written in each cell. + signifies potential ceiling effects, indicating that the process was implemented in >90% of cases in phase 1.
Figure 5Associations between the PROs and processes. Cells in green depict significant regression coefficients indicating a favorable association between process variable and PRO (e.g. receiving information about treatment options is associated with a lower risk of reporting worst ≥ 6/10 NRS). Correspondingly, red cells depict significant regression coefficients indicating an unfavorable association between process variable and PRO (eg, receiving systemic opioids is associated with a higher risk of reporting nausea ≥ 4/10 NRS). Asterisks indicate significant associations after applying the Bonferroni-Holm correction for multiple comparisons and adjusted for p values of less than 0.05.